Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Elevation Oncology (ELEV) has shared an announcement.
Lori Hu has resigned from her position on the Board of Directors of Elevation Oncology, Inc., effective April 5, 2024. Her departure is amicable, with no disagreements cited regarding the company’s operations or practices. The Board expresses gratitude for Hu’s contributions and welcomes Darcy Mootz, Ph.D., to the Audit Committee, where she will assume the role vacated by Hu.
For a thorough assessment of ELEV stock, go to TipRanks’ Stock Analysis page.
